Lupin Atlantis Holdings SA v. Apotex Inc.
1:11-cv-03853
Overview
Parties
Defendant
Ethypharm SA NPE (Individual / Inventor)
Represented By
6 Attorneys ListedStradley Ronon Stevens & Young, LLP
300 Delaware Avenue, Suite 800
Baker Botts LLP (NY)
30 Rockefeller Plaza, 44th Floor
DeVore & DeMarco, L.L.P.
DeVore & DeMarco, L.L.P., 99 Park Avenue
Baker Botts LLP (NY)
30 Rockefeller Plaza, 44th Floor
DeVore & DeMarco, L.L.P.
DeVore & DeMarco, L.L.P., 99 Park Avenue
Apotex Corp. Operating Company
Represented By
2 Attorneys ListedFlaster/Greenberg P.C.
1810 Chapel Avenue West, Cherry Hill, NJ 08002
Plaintiff
Lupin Atlantis Holdings SA Operating Company
Represented By
2 Attorneys ListedProctor Heyman LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
DeVore & DeMarco, L.L.P.
DeVore & DeMarco, L.L.P., 99 Park Avenue
Interested Party
Apotex Inc. Operating Company
Represented By
2 Attorneys ListedFlaster/Greenberg P.C.
1810 Chapel Avenue West, Cherry Hill, NJ 08002
Court & Judges
Court
District Court, S.D. New York (nysd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π«π· France | France Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7101574
Pharmaceutical composition containing fenofibrate and the preparation method
|
Filed: 2000-07-07
Issued: 2006-09-05
|
Expired (Term Ended)
+44d PTA
Expires: 2020-08-20
|
|
|
US7863331
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
Filed: 2003-10-03
Issued: 2011-01-04
|
Expired (Term Ended)
+76d PTA
Expires: 2023-12-18
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
72
Dispositive
8
Granted
1
Denied
0
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings